ID
11954
Description
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger
Keywords
Versions (2)
- 8/25/15 8/25/15 - Martin Dugas
- 8/26/15 8/26/15 - Martin Dugas
Uploaded on
August 26, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
End of Study Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147
End of Study Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: SE
Description
Studienabbruch Grund RQG
Description
Studienabbruch verletztes Ein/Aus
Data type
text
Similar models
End of Study Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: SE
C0444496 (UMLS CUI-2)